Skip to content
Home/Companies/MedTech/Axon Vascular Europe

Axon Vascular Europe

MedTech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Axon Vascular Europe?

Axon Vascular Europe is currently owned by Earlybird Venture Capital through Earlybird Health (2017 vintage), since 2025.

Hand-verified · updated 2026-08-10

Earlybird Venture Capital
Investor
Earlybird Venture Capital
Earlybird Health · 2017 · VC

Key facts

HQUnited Kingdom
SectorMedTech
StatusActive

More from Earlybird Health

Other portfolio companies in the same fund.

Haya Therapeutics
Haya Therapeutics
Active
BiotechSwitzerland· 2025
Hilo
Hilo
Active
MedTechSwitzerland· 2025
Portal Biotech
Active
BiotechUK· 2025
Rivia
Active
HealthTechSwitzerland· 2025
Gemma Biotherapeutics
Gemma Biotherapeutics
Active
BiotechUS· 2024
Prothea Technologies
Prothea Technologies
Active
MedTechUK· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Axon Vascular Europe

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Axon Vascular Europe?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Axon Vascular Europe.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue